▟ Vinebot intrinsic value, daily

← back

BDX Becton Dickinson

healthcare · valued with glm-5.2 medium conviction · deep-dived 2026-08-19

STRONG SELL
Intrinsic value$0.00
Price (at call)$180.77
Margin of safety -100.0%
vs market (rating basis) -74.0%

Model unavailable; showing baseline valuation.

⚠ LLM error: empty response; using baseline

The story

Value drivers

Revenue growth (Y1)5.0%
Terminal growth3.5%
Forecast horizon10y
Target operating margin10.0%
Years to target margin5
Sales-to-capital0.50
Beta0.50
Failure probability0.0%
Cost of capital (WACC)7.7%
Terminal WACC9.3%

Valuation bridge

PV of explicit FCFF1.24B
PV of terminal value14.96B
Equity value0
÷ shares → per share$0.00

News

bullish +0.30 · 8 articles

  • Are Wall Street Analysts Predicting Becton, Dickinson and Company Stock Will Climb or Sink?
  • WST Stock Surges 38.1% Since March-End: What's Fueling the Rally?
  • How Much More Can Boston Scientific Stock Move After Losing Half Its Value?
  • Buy, Sell, or Hold These 4 Dividend Kings After Earnings: BDX, ED, EMR, PH
  • WST Gains 15.3% in Three Months as HVP Growth Strengthens Outlook
  • Omnicell Raises 2026 EPS Outlook as Memory Costs Pressure Margins
  • Boston Scientific Stock Is Priced As If WATCHMAN Were The Whole Company
  • Jim Cramer Sees Cheap Valuation in Becton, Dickinson (BDX) After Q3 Beat and Raised Guidance

Projected free cash flow to the firm

YrRevenueGrowthMarginNOPATReinvestFCFFPV
1 21.88B 5.0% 10.0% 1.95B 2.08B -128.22M -119.07M
2 22.94B 4.8% 10.0% 2.05B 2.11B -65.27M -56.29M
3 24.01B 4.7% 10.0% 2.14B 2.14B 4.28M 3.43M
4 25.08B 4.5% 10.0% 2.24B 2.16B 80.57M 59.92M
5 26.17B 4.3% 10.0% 2.34B 2.17B 163.71M 113.06M
6 27.26B 4.2% 10.0% 2.43B 2.18B 253.75M 162.75M
7 28.35B 4.0% 10.0% 2.53B 2.18B 350.72M 208.89M
8 29.44B 3.8% 10.0% 2.63B 2.17B 454.60M 251.45M
9 30.52B 3.7% 10.0% 2.72B 2.16B 565.33M 290.38M
10 31.58B 3.5% 10.0% 2.82B 2.14B 682.78M 325.68M

⚠ intrinsic value floored at 0 — the drivers imply the equity claim is worth less than the debt ahead of it · Extreme gap to market price — large, heavily-covered stocks are rarely mispriced this much; the gap likely embeds disruption, decline, or balance-sheet risk the model underweights. Treat as a flag to investigate, not a verdict.

History

DatePriceIntrinsicMoSRating
2026-08-19$180.77 $0.00 -100.0% STRONG SELL
2026-06-29$155.92 $49.14 -68.5% SELL
2026-06-23$143.94 $70.76 -50.8% HOLD